Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control
Journal for ImmunoTherapy of Cancer · 2025-07 · 13 (7) · e010672
DOI: 10.1136/jitc-2024-010672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 23.07.2025. Verfasst von Matthew Dysthe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Killer Cells, Natural, Receptors, Chimeric Antigen, Interleukin-7. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HSRD VA, Alex’s Lemonade Stand Foundation for Childhood Cancer, American Cancer Society.
Abstract (Originalsprache)
Background
Adoptive transfer of chimeric antigen receptor (CAR)-expressing natural killer (NK) cells has demonstrated success against hematological malignancies. Efficacy against solid tumors has been limited by poor NK cell survival and function in the suppressive tumor microenvironment (TME). To enhance efficacy against solid tumors, stimulatory cytokines have been incorporated into CAR-NK cell therapeutic approaches. However, current cytokine strategies have limitations, including systemic toxicities, exogenous dependencies, and unwanted TME bystander effects. Here, we aimed to overcome these limitations by modifying CAR-NK cells to express a constitutively active interleukin (IL)-7 receptor, termed C7R, capable of providing intrinsic CAR-NK cell activation that does not rely on or produce exogenous signals nor activate bystander cells.
Methods
We examined persistence, antitumor function, and transcriptional profiles of CAR-NK cells coexpressing C7R in a novel tumor immune microenvironment (TiME) co-culture system and against hematologic and solid tumor xenografts in vivo.
Results
Peripheral blood NK cells expressing a CAR directed against the solid tumor antigen GD2 and modified with C7R demonstrated enhanced tumor killing and persistence in vitro compared with CAR-NK cells without cytokine support and similar functions to CAR-NK cells supplemented with recombinant IL-15. C7R.CAR-NK cells exhibited enhanced survival and proliferation within neuroblastoma TiME xenografts in vivo but produced poor long-term tumor control compared with CAR-NK cells supplemented with IL-15. Similar results were seen using C7R-expressing CD19.CAR-NK cells against CD19+leukemia xenografts. Gene expression analysis revealed that chronic signaling via C7R induced a transcriptional signature consistent with intratumor stressed NK cells with blunted effector function. We identified gene candidates associated with chronic cytokine-stressed NK cells that could be targeted to reduce CAR-NK cell stress within the solid TME.
Conclusion
C7R promoted CAR-NK cell survival in hostile TMEs independent of exogenous signals but resulted in poor antitumor function in vivo. Our data reveals the detrimental role of continuous IL-7 signaling in CAR-NK cells and provides insights into proper application of cytokine signals when attempting to enhance CAR-NK cell antitumor activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Immunology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
- Pediatrics-Oncology, Baylor College of Medicine, Houston, Texas, USA.
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.
- Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USA rparihar@bcm.edu.
Förderung
- HSRD VA
- Alex’s Lemonade Stand Foundation for Childhood Cancer
- American Cancer Society
Zitieren
APA
Dysthe, M., Navin, I., van Leeuwen, D., Pineda, J., Baumgartner, C., Rooney, C. M., & Parihar, R. (2025). Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control. Journal for ImmunoTherapy of Cancer, 13(7), e010672. https://doi.org/10.1136/jitc-2024-010672
Vancouver
Dysthe M, Navin I, van Leeuwen D, Pineda J, Baumgartner C, Rooney CM, et al. Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control. Journal for ImmunoTherapy of Cancer. 2025;13(7):e010672. doi:10.1136/jitc-2024-010672
BibTeX
@article{Dysthe2025,
author = {Dysthe, Matthew and Navin, Ishwar and van Leeuwen, Dayenne and Pineda, Josue and Baumgartner, Corrine and Rooney, Cliona M and Parihar, Robin},
title = {Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {7},
pages = {e010672},
doi = {10.1136/jitc-2024-010672}
}
EUVIMED